Lillioja S, Bogardus C
Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona 58016.
Diabetes Metab Rev. 1988 Aug;4(5):517-40. doi: 10.1002/dmr.5610040508.
Diabetes and obesity are epidemic in the Pima Indians of the Southwestern United States, and the prevalence of diabetes is increasing. The most likely link between obesity and diabetes is tissue insulin resistance. If obesity is defined as an excess of body fat, then it can only be accurately assessed by measurements of body composition and not by approximations such as body mass index or percent of ideal weight. To compare the metabolic data of individuals of varying size, an accurate measure of metabolic size is needed. Total body weight is not an appropriate means of comparing individuals since obese subjects have a greater proportion of nonmetabolizing mass (triglyceride). Body surface area shows a sex difference, and this may distort data if both sexes are present. From studies of metabolic rate we have determined that metabolic rate is directly proportional to the fat-free mass plus 18 kg, and we suggest that this weight can be equated with metabolic size. Glucose storage in skeletal muscle appears to be important in the disposal of an intravenous glucose load. Consistent with its role in glycogen storage, glycogen synthase enzyme is activated in proportion to the ability to dispose of glucose during a hyperinsulinemic, euglycemic clamp. The role of glycogen synthase is most notable at supraphysiological plasma insulin concentrations; and since glucose uptake at these insulin concentrations is highly familial independent of the degree of obesity, we suggest that there may be a specific genetic defect expressed in skeletal muscle that reduces insulin responsiveness in some subjects. The lack of correlation between 24 hour respiratory quotient measured in a metabolic chamber (a measure of the proportion of fat derived calories) and degree of obesity indicates that in obese Pima Indians insulin resistance is not due to an inhibition of glucose metabolism by free fatty acids (glucose-fatty acid-ketone cycle). Obesity is associated with an increase in fat-free mass almost kilogram- for kilogram with fat mass when compared to the lean state. A role for this increase in fat-free tissue in producing insulin resistance has been given insufficient attention in the past. With an increase in fat-free mass, muscle cells are hypertrophied and capillaries in muscle are more widely spaced. We propose that these biophysical changes in muscle mediate, at least in part, the effects of obesity to produce a reduction in insulin sensitivity and the abnormal kinetics of insulin action found in the obese.(ABSTRACT TRUNCATED AT 400 WORDS)
糖尿病和肥胖症在美国西南部的皮马印第安人中极为普遍,且糖尿病的患病率还在上升。肥胖与糖尿病之间最可能的联系是组织胰岛素抵抗。如果将肥胖定义为体内脂肪过多,那么只能通过测量身体成分来准确评估,而不能通过诸如体重指数或理想体重百分比等近似值来评估。为了比较不同体型个体的代谢数据,需要一种准确的代谢体型测量方法。总体重不是比较个体的合适方式,因为肥胖受试者的非代谢性物质(甘油三酯)比例更高。体表面积存在性别差异,如果同时有男性和女性,这可能会使数据失真。通过对代谢率的研究,我们确定代谢率与去脂体重加18千克成正比,我们认为这个体重可以等同于代谢体型。骨骼肌中的葡萄糖储存似乎在处理静脉注射葡萄糖负荷中很重要。与其在糖原储存中的作用一致,糖原合酶在高胰岛素正常血糖钳夹期间与处理葡萄糖的能力成比例地被激活。糖原合酶的作用在超生理血浆胰岛素浓度时最为显著;并且由于在这些胰岛素浓度下的葡萄糖摄取高度具有家族性,与肥胖程度无关,我们认为可能存在一种在骨骼肌中表达的特定基因缺陷,导致一些受试者的胰岛素反应性降低。在代谢室中测量的24小时呼吸商(一种衡量脂肪衍生热量比例的指标)与肥胖程度之间缺乏相关性,这表明在肥胖的皮马印第安人中,胰岛素抵抗并非由于游离脂肪酸对葡萄糖代谢的抑制(葡萄糖 - 脂肪酸 - 酮循环)。与瘦体型状态相比,肥胖与去脂体重几乎与脂肪量以千克为单位的增加相关。过去,这种去脂组织增加在产生胰岛素抵抗中的作用未得到充分关注。随着去脂体重的增加,肌肉细胞肥大,肌肉中的毛细血管间距更宽。我们提出,肌肉中的这些生物物理变化至少部分介导了肥胖导致胰岛素敏感性降低以及肥胖者中发现的胰岛素作用异常动力学的影响。(摘要截选至400字)